Results 231 to 240 of about 95,738 (356)

Impact of automated insulin delivery on subjective and objective sleep in children and young adults with very high HbA1c: Sleep outcomes from the CO‐PILOT randomised controlled trial

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims To assess how automated insulin delivery (AID) impacts sleep in young people with type 1 diabetes and suboptimal glycaemia (HbA1c ≥ 69 mmol/mol). Methods We conducted a randomised controlled trial comparing AID to usual care in 80 participants (aged 7–25 years) over 13 weeks. Sleep was a secondary outcome assessed at baseline and 13 weeks
Venus R. Michaels   +11 more
wiley   +1 more source

Long‐term outcomes following alternative second‐line oral glucose‐lowering treatments: Results from the real‐world progression in type 2 diabetes mellitus United Kingdom (RAPIDS‐UK) model

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare long‐term complications for people with type 2 diabetes mellitus (T2DM) following second‐line treatment in routine practice with sulphonylureas (SU), dipeptidyl peptidase‐4 inhibitors (DPP4i), or sodium‐glucose co‐transporter‐2 inhibitors (SGLT2i) added to metformin.
Orlagh U. Carroll   +8 more
wiley   +1 more source

Microalbuminuria and glycated hemoglobin in children with type 1 diabetes mellitus [PDF]

open access: hybrid, 2014
Magdy Omar   +3 more
openalex   +1 more source

Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Lipoprotein(a) [Lp(a)] is a genetically determined, causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease (CAVD). Despite robust evidence from epidemiological and genetic studies, Lp(a) remains underrecognised in clinical practice due to challenges in measurement, lack of guideline familiarity ...
Alexander C. Razavi   +4 more
wiley   +1 more source

Molten Globule of Hemoglobin Proceeds into Aggregates and Advanced Glycated End Products

open access: gold, 2013
Afshin Iram   +5 more
openalex   +2 more sources

Cost‐effectiveness of ON101 with general wound care for diabetic foot ulcers among patients with type 2 diabetes in Singapore: Analysis of a multi‐ethnic country in Asia

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetic foot ulcers (DFUs) impose a vast health and economic burden on individuals and healthcare systems globally. We assessed the cost‐effectiveness of adding ON101, a novel treatment for accelerating wound healing, to general wound care (GWC) versus GWC alone for DFUs in Singapore, a multi‐ethnic country with increasing DFU prevalence
Hsuan‐Yu Su   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy